Most enterprise teams pushing into AI hit a wall, not because AI isn't capable, but because the content foundation underneath (i.e., page-based systems storing blobs) wasn't designed for this era. AI needs structure, relationships, governance, and real-time data. Today, Sanity announces the evolution of its platform as the Content Operating System for the AI era: […]
New York, New York, March 04, 2026 (GLOBE NEWSWIRE) — The Tunnel to Towers Foundation is expanding its commitment to the families of America's heroes, with the launch of a national scholarship program. Named in honor of Tunnel to Towers Chairman and CEO Frank Siller's mother and father, the Mae and George Siller Tunnel to
Tunnel to Towers Foundation Announces Full Scholarships for Children of America's Fallen and Injured Heroes The Mae and George Siller Scholarship Program Will Cover Full Tuition for Gold Star Children, Children of Fallen First Responders, and Children of Injured Veterans and First Responders GlobeNewswire March 04, 2026 New York, New York, March 04, 2026 (GLOBE
(NASDAQ:RARE), SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) common stock between August 3, 2023 and December 26, 2025. Ultragenyx is a biopharmaceutical company focused on rare and ultrarare genetic
Robbins LLP Urges RARE Stockholders to Contact the Firm for Information About the Class Action Against Ultragenyx Pharmaceutical Inc. GlobeNewswire March 04, 2026 SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) — Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ultragenyx Pharmaceutical Inc. (NASDAQ:
(NASDAQ:CRWV), SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) — National shareholder rights law firm Hagens Berman provides an update to investors in CoreWeave, Inc. (NASDAQ: CRWV) following the company's dismal fourth-quarter 2025 financial results. The news follows allegations that the company concealed operational failures, as pled in a recently filed securities class action. Hagens Berman
CRWV Alert: Hagens Berman Analyzes CoreWeave (CRWV) $452M Q4 Loss and Soft Guidance Amid Ongoing Securities Fraud Litigation Q4 Net Loss Nearly Doubles Estimates; Firm Reminds Investors of March 13 Lead Plaintiff Deadline GlobeNewswire March 04, 2026 SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) — National shareholder rights law firm Hagens Berman provides an update
RBL LLC biotechnology startup SteerBio to drive clinical development and commercialization A team of researchers led by Rice University bioengineer Omid Veiseh has been awarded $18.2 million in funding from the Advanced Research Projects Agency for Health (ARPA-H) to develop a first-of-its-kind regenerative treatment aimed at restoring damaged lymphatic vessels and potentially curing lymphedema, a
Predictors of Success for 60-Day Peripheral Nerve Stimulation (PNS) Used for Treatment of Chronic Shoulder Pain: A Multi-Center Retrospective Chart Review – Bimodal stimulation produced significantly higher shoulder pain relief compared to other stimulation paradigms – GlobeNewswire March 04, 2026 CLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) — Shoulder pain is one of the most common
ERLANGER, Ky., March 04, 2026 (GLOBE NEWSWIRE) — DAV (Disabled American Veterans) has announced its continued partnership with Humana, one of the nation's leading health and well-being companies. The relationship builds on Humana's long-standing commitment to supporting veterans and expands its investment in organizations that provide critical programs and services for veterans and their families.